Treatment with SLR10 seemed to increase the severity of pathologic lesions in both CS (CS SLR10 PR8) and NS (NS SLR10 PR8) mice, though it did not reach statistical significance, and it may reflect enhanced inflammatory recruitment.
← all excerpts
RIG-I agonist SLR10 promotes macrophage M1 polarization during influenza virus infection.
1
—
—